-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Inhibrx Biosciences, Inc. quarterly General and Administrative Expense history and growth rate from Q2 2023 to Q3 2024.
- Inhibrx Biosciences, Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $7.9M, a 0.19% increase year-over-year.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)